Understanding How Many Doses Are in an Ozempic 1 mg Pen

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Understanding your medication's dose schedule helps you plan refills and track your weight loss progress. Ozempic pens come in 0.5 mg, 1 mg, 2 mg, and 4 mg strengths, each containing multiple doses delivered over several weeks. PlexusDx provides compounded semaglutide injections with clear dosing guidance and transparent monthly pricing.

How Ozempic Pens Deliver Multiple Doses

A 1 mg Ozempic pen is not a single-dose delivery device—it contains enough semaglutide to provide four separate weekly injections of 0.25 mg each. The pen's built-in mechanism allows you to dial and click for each weekly dose, making it convenient for once-weekly GLP-1 therapy. After four weeks of injections, the pen empties and you move to the next strength or refill, depending on your clinical protocol.

The compartmentalized design prevents medication waste and ensures consistent dosing across your treatment cycle. Each click releases exactly the amount prescribed by your healthcare provider, removing guesswork from self-administration. This precision is why many patients prefer injectable GLP-1 medications over other delivery methods.

Semaglutide Dose Escalation and Refill Schedules

Most weight loss protocols begin with a low starting dose of 0.25 mg and escalate gradually every four weeks to minimize side effects and build tolerance. During this escalation phase, you may use multiple pen strengths sequentially—starting with a 0.5 mg pen, then moving to 1 mg, 2 mg, or 4 mg pens as your dose increases. Refill frequency depends entirely on your current dose level and how quickly you advance through the titration schedule.

Your healthcare provider determines the escalation timeline based on your response, tolerability, and weight loss goals. Some patients reach their target dose within 8–12 weeks, while others may take longer. Tracking your injection dates helps prevent missed doses and ensures you reorder well before your current pen runs out.

PlexusDx Compounded Semaglutide vs. Brand Ozempic

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies at a flat monthly rate of $189, eliminating the dose-dependent pricing confusion that comes with brand medications. Unlike brand Ozempic, which requires insurance navigation or high out-of-pocket costs, PlexusDx compounded injections are available nationwide with no insurance needed. Your dose may increase as you progress—your price will not.

Compounded semaglutide contains the same active pharmaceutical ingredient as brand Ozempic but is prepared by licensed compounders specifically for weight loss therapy. PlexusDx also offers oral semaglutide for patients who prefer tablets over injections, both with transparent, flat-rate pricing. Each patient receives clear dosing instructions and refill reminders tailored to their specific protocol.

Personalized Dosing Through Genetic Testing at PlexusDx

PlexusDx's Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways and 150+ health insights, helping optimize your semaglutide response and ideal dose trajectory. Key variants like GIPR rs1800437 influence how your body responds to GLP-1 therapy, informing whether you may benefit from higher or lower escalation speeds. This personalized approach means your dosing plan is tailored to your unique biology, not a one-size-fits-all schedule.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How many actual injections does one Ozempic 1 mg pen provide?

An Ozempic 1 mg pen contains four weekly doses of 0.25 mg each, for a total of four injections over one month. After the four weeks, you either refill the same strength or move to a higher strength as part of dose escalation. PlexusDx patients receive detailed injection schedules with their monthly supply.

Why does semaglutide dosing increase over time?

Starting with a low dose (0.25 mg) minimizes gastrointestinal side effects and allows your body to adapt to GLP-1 therapy. Gradual escalation over 8–12 weeks to a target maintenance dose (typically 0.5–1.0 mg weekly) improves tolerability and weight loss results. Clinical trials show this escalation approach yields better long-term adherence and metabolic outcomes.

How much does PlexusDx semaglutide cost each month?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with a flat-rate pricing model across all dose levels—your dose may increase, but your price won't. The medication is HSA/FSA eligible, available nationwide without insurance, and includes personalized dosing protocols tailored to your goals.

Are there side effects associated with dose escalation?

Common early side effects include nausea, appetite suppression, and mild gastrointestinal symptoms, which typically diminish as your body adapts during escalation. Starting low and increasing gradually significantly reduces severe side effects compared to starting at higher doses. If side effects become intolerable, your PlexusDx provider can adjust your escalation pace.

How does the Precision Peptide Genetic Test improve my dosing plan?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy 025 Mg 05 Ml Pen
• Maximus Glp 1
• Lifemd Ozempic
• Found Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.